TY - CHAP
T1 - Molecular and clinical aspects of ghrh receptor mutations
AU - Corazzini, Valentina
AU - Salvatori, Roberto
PY - 2013
Y1 - 2013
N2 - The growth hormone (GH)-releasing hormone (GHRH) receptor (GHRHR) belongs to the G protein-coupled receptor family. It binds GHRH resulting in somatotroph cell proliferation and stimulation of GH secretion. Mutations in the gene encoding for GHRHR (GHRHR, OMIM No. 139191) are being reported with increasing frequency in familial isolated GH deficiency. To date, the reported GHRHR mutations include eight missense, seven splice, three microdeletions, and two non-sense mutations. One promoter mutation has also been reported. Most of these mutations show a recessive mode of inheritance. The phenotype includes reduced but not absent serum GH, with abnormal response to a variety of stimuli, and low serum insulin-like growth factor-1 levels, resulting in proportionate growth failure which becomes evident in the first year of life. These patients respond well to GH replacement therapy. Phenotypical observations coming from some unusually large kindreds with untreated GH deficiency due to homozygous GHRHR mutations have allowed the study of the consequences of lifetime lack of GH. This chapter reviews the structure and the role of the GHRHR together with the clinical aspects associated with its mutations.
AB - The growth hormone (GH)-releasing hormone (GHRH) receptor (GHRHR) belongs to the G protein-coupled receptor family. It binds GHRH resulting in somatotroph cell proliferation and stimulation of GH secretion. Mutations in the gene encoding for GHRHR (GHRHR, OMIM No. 139191) are being reported with increasing frequency in familial isolated GH deficiency. To date, the reported GHRHR mutations include eight missense, seven splice, three microdeletions, and two non-sense mutations. One promoter mutation has also been reported. Most of these mutations show a recessive mode of inheritance. The phenotype includes reduced but not absent serum GH, with abnormal response to a variety of stimuli, and low serum insulin-like growth factor-1 levels, resulting in proportionate growth failure which becomes evident in the first year of life. These patients respond well to GH replacement therapy. Phenotypical observations coming from some unusually large kindreds with untreated GH deficiency due to homozygous GHRHR mutations have allowed the study of the consequences of lifetime lack of GH. This chapter reviews the structure and the role of the GHRHR together with the clinical aspects associated with its mutations.
UR - http://www.scopus.com/inward/record.url?scp=84875437464&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84875437464&partnerID=8YFLogxK
U2 - 10.1159/000342575
DO - 10.1159/000342575
M3 - Chapter
C2 - 23392099
AN - SCOPUS:84875437464
SN - 9783318022674
T3 - Endocrine Development
SP - 106
EP - 117
BT - Hormone Resistance and Hypersensitivity
A2 - Maghnie, Mohamad
A2 - Lorini, Renata
A2 - Loche, Sandro
A2 - Cappa, Marco
A2 - Ghizzoni, Lucia
ER -